Pharma Sector

The said indication is for the use of durvalumab in combination with chemotherapy as a neoadjuvant treatment.

Earlier this year, Bajaj Healthcare secured formal CMO agreements with customers in the United Kingdom and the European Union to deliver 15 APIs.

Bayshore Pharmaceuticals is a 100% subsidiary of Unichem Laboratories' parent firm, Ipca Laboratories Ltd.

Abhay Soi, Max Healthcare's Chairman and Managing Director, stated that the acquisition improves Max's foothold in the NCR region.

As per USFDA, the facility did not thoroughly analyse contamination across medicine batches and continued to issue compromised items.

The USFDA has also noted a repeat observation from the company's January 2023 inspection.

Eugia Steriles, a 100% subsidiary of Eugia Pharma Specialities and a step down arm of Aurobindo Pharma, operates the new plant.

In September 2023, the pharmaceutical behemoth revealed OneSource. The stock exchanges approved the idea earlier this year, in May.

According to the firm, the NDA submission package is based on three clinical trials, many pre-clinical investigations.

Natco Pharma disclosed that its subsidiary will invest USD 8 million in eGenesis, acquiring a total of 40,629,761 shares.